Q1 2026 Holdings
Filed 2026-05-15 | 10 holdings | $677.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $123.0M | 4,120,053 | 18.2% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $116.7M | 3,728,738 | 17.2% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $115.7M | 12,916,663 | 17.1% |
| Erasca Inc(ERAS) | COM | 29479A108 | $114.7M | 7,091,557 | 16.9% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $108.2M | 4,540,132 | 16.0% |
| Lyell Immunopharma Inc(LYEL) | COM NEW | 55083R203 | $65.1M | 3,247,162 | 9.6% |
| Generate Biomedicines Inc(GENB) | COM SHS | 370920100 | $24.3M | 1,944,426 | 3.6% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $4.6M | 217,834 | 0.7% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $2.6M | 8,055,916 | 0.4% |
| Q32 BIO Inc(QTTB) | COM | 746964105 | $2.1M | 320,482 | 0.3% |